1,601
Participants
Start Date
September 23, 2021
Primary Completion Date
October 19, 2024
Study Completion Date
October 19, 2024
Treatment as usual + cerebral oximetry monitoring the first 72 hours of life
SafeBoosC - Safeguarding the Brain of Our Smallest Children - an Investigator-initiated Randomised, Blinded, Multinational, Phase II Feasibility Clinical Trial on Near-infrared Spectroscopy Monitoring Combined With Defined Treatment Guidelines Versus Standard Monitoring and Treatment as Usual in Premature Infants
Righospitalet (The University Hospital, Copenhagen), Copenhagen
Gorm Greisen
OTHER